Bevacizumab for Initial GBM Therapy Doesnât Extend Life
Radiation Therapy Oncology Group (RTOG)A Radiation Therapy Oncology Group trial found that adding bevacizumab to initial treatment for glioblastoma did not improve patient overall survival or progression-free survival,. Results were reported June 2 at the plenary session of the American Society of Clinical Oncology 2013 Annual Meeting.